Asthika Goonewardene
Stock Analyst at Truist Securities
(1.47)
# 3,471
Out of 5,049 analysts
94
Total ratings
41.57%
Success rate
-10.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMAB Genmab | Reiterates: Buy | $49 → $48 | $28.70 | +67.25% | 16 | Nov 7, 2025 | |
| GILD Gilead Sciences | Reiterates: Buy | $127 → $145 | $119.83 | +21.00% | 3 | Nov 3, 2025 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $32 → $39 | $18.66 | +109.00% | 2 | Oct 7, 2025 | |
| MRUS Merus | Downgrades: Hold | $88 → $97 | $95.19 | +1.90% | 3 | Sep 29, 2025 | |
| JANX Janux Therapeutics | Initiates: Buy | $100 | $25.63 | +290.17% | 1 | Sep 10, 2025 | |
| RVMD Revolution Medicines | Initiates: Buy | $99 | $59.73 | +65.75% | 1 | Sep 5, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $250 → $36 | $7.80 | +361.83% | 5 | Aug 14, 2025 | |
| EXEL Exelixis | Maintains: Buy | $56 → $49 | $40.06 | +22.32% | 11 | Jul 29, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $100.70 | +53.92% | 3 | Jun 3, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $31.40 | +126.11% | 2 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $10 | $1.10 | +809.09% | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.30 | +672.20% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.13 | +605.88% | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $17.62 | +98.64% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $84.98 | +60.04% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $0.80 | +1,775.00% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.56 | +156.41% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.98 | +859.60% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $0.62 | +4,268.93% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $13.93 | +761.45% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $1.68 | +3,482.09% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $228 → $180 | $9.82 | +1,732.99% | 4 | Aug 23, 2022 |
Genmab
Nov 7, 2025
Reiterates: Buy
Price Target: $49 → $48
Current: $28.70
Upside: +67.25%
Gilead Sciences
Nov 3, 2025
Reiterates: Buy
Price Target: $127 → $145
Current: $119.83
Upside: +21.00%
Arcus Biosciences
Oct 7, 2025
Reiterates: Buy
Price Target: $32 → $39
Current: $18.66
Upside: +109.00%
Merus
Sep 29, 2025
Downgrades: Hold
Price Target: $88 → $97
Current: $95.19
Upside: +1.90%
Janux Therapeutics
Sep 10, 2025
Initiates: Buy
Price Target: $100
Current: $25.63
Upside: +290.17%
Revolution Medicines
Sep 5, 2025
Initiates: Buy
Price Target: $99
Current: $59.73
Upside: +65.75%
Mersana Therapeutics
Aug 14, 2025
Maintains: Buy
Price Target: $250 → $36
Current: $7.80
Upside: +361.83%
Exelixis
Jul 29, 2025
Maintains: Buy
Price Target: $56 → $49
Current: $40.06
Upside: +22.32%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $100.70
Upside: +53.92%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $31.40
Upside: +126.11%
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.10
Upside: +809.09%
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.30
Upside: +672.20%
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.13
Upside: +605.88%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $17.62
Upside: +98.64%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $84.98
Upside: +60.04%
Aug 16, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $0.80
Upside: +1,775.00%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.56
Upside: +156.41%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.98
Upside: +859.60%
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $0.62
Upside: +4,268.93%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $13.93
Upside: +761.45%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $1.68
Upside: +3,482.09%
Aug 23, 2022
Maintains: Buy
Price Target: $228 → $180
Current: $9.82
Upside: +1,732.99%